This document discusses the lincosamide antibiotics clindamycin and lincomycin. Clindamycin is a potent lincosamide antibiotic that inhibits protein synthesis by binding to the 50s ribosome. It has a similar spectrum of activity to erythromycin and is effective against most gram-positive cocci, diphtheria, nocardia, and actinomyces. Common side effects include rashes, diarrhea, and pseudomembranous colitis caused by C. difficile infection. Clindamycin is restricted to anaerobic infections and is used for Bacteroides fragilis infections of the abdomen, pelvis, and lungs. Lincomycin was the predecessor to cl